What is the fair value of AVXL stock?

Our analysis estimates the fair value range for AVXL to be between $3.82 and $5.01. The current price is $4.70.

What is the analyst price target for AVXL?

The average Wall Street analyst price target for AVXL is $22.00. This implies a potential upside of 348.1% from current levels.

AVXL Stock Analysis: Buy, Sell, or Hold?

AVXL - Anavex Life Sciences

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

$4.70

-0.21 (-4.28%) ▼

WAIT

LOW Confidence

Protect Your AVXL Gains

Last Updated: January 30, 2026

Earnings: Feb 11, 2026 10d

Smart Money Accumulation

AVXL is down 10.6% this week, but smart money is accumulating calls. Top strike: $5 2026-04-17 with 762 OI. Call ratio: 62% View Scanner →

Strength: 6.5/10

Get Alerted When AVXL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
⏸️ WAIT FOR STABILIZATION: AVXL is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 10.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$6.58

Based on 7.0% avg growth

INTRINSIC VALUE TODAY

$4.09

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.7x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: AVXL is currently trading at $4.70, which is considered fair relative to its 30-day fair value range of $3.82 to $5.01. The stock's valuation (Forward PE: 3.9) is in line with its historical norms (3.7). At these levels, the market is pricing in 1.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, AVXL is in a strong downtrend. The price is currently testing key support at $4.68. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.

Market Sentiment: AVXL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.00 (+348.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR

Fair Price Range $3.82 - $5.01

Company Quality Score 63/100 (BUY)

Volume Confirmation HIGH

Confidence Score 79.5%

Protect Your Profits

Holding AVXL? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Price in fair range
BULLISH: Strong technical setup (75/100)
BULLISH: High volume confirmation
BEARISH: Downward momentum (-4.3%)
BULLISH: Trading 348.1% below Wall St target ($22.00)
NEUTRAL: Market pricing in 1.9% annual earnings growth - fairly valued
WARNING: Recommendation downgraded due to -10.6% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $3.82 - $5.01

Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $4.68

Resistance Level $5.36

Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 3.87

Wall Street Target $22.00 (+348.1%)

Valuation Premium vs History +1.9% premium

PE vs Historical 3.9 vs 3.7 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +1.9% (market-implied from PE analysis)

1-Year Target $5.00 (+2%)

2-Year Target $5.10 (+4%)

3-Year Target $5.20 (+6%)

3-Yr Target (if PE normalizes) (PE: 4→4) PE COMPRESSION $4.97 (+1%)

Earnings growth offset by PE compression

Last updated: January 31, 2026 1:20 PM ET
Data refreshes hourly during market hours. Next update: 2:20 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is AVXL showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
SRPT Sarepta Therapeutics Inc	STRONG BUY 26 analysts	$21	54 HOLD
ALNY Alnylam Pharmaceuticals …	STRONG BUY 33 analysts	$486	45 HOLD
VRTX Vertex Pharmaceuticals I…	BUY 34 analysts	$500	62 BUY
IONS Ionis Pharmaceuticals Inc	BUY 26 analysts	$91	64 BUY
REGN Regeneron Pharmaceutical…	STRONG BUY 25 analysts	$830	52 HOLD

SRPT Sarepta Therapeut…

54 HOLD

ALNY Alnylam Pharmaceu…

45 HOLD

VRTX Vertex Pharmaceut…

62 BUY

IONS Ionis Pharmaceuti…

64 BUY

REGN Regeneron Pharmac…

52 HOLD

Advanced AVXL Option Strategies

Professional options setups generated by AI based on today's AVXL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for AVXL

AVXL Technical Chart AVXL Price Prediction AVXL Earnings Date AVXL Investment Advisor AVXL Fair Price Analyzer AVXL Options Advisor AVXL Options Chain AVXL Options Analysis AVXL Competitors

Compare AVXL with Other Stocks

AVXL vs NBIX

AVXL vs BNTX
Winner: Tie

Create New Comparison

Tradestie